(Q33955164)

30 July 2017

1 reference

title

The pathogenesis of Ebola hemorrhagic fever (English)

1 reference

30 July 2017

main subject

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

author name string

Takada A

series ordinal

1

1 reference

30 July 2017

Kawaoka Y

series ordinal

2

1 reference

30 July 2017

publication date

1 October 2001

1 reference

30 July 2017

published in

Trends in Microbiology

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

506-511

1 reference

A system for functional analysis of Ebola virus glycoprotein

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Host cell proteases controlling virus pathogenicity

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

An analysis of features of pathogenesis in two animal models of Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Human asymptomatic Ebola infection and strong inflammatory response

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

The Ebola virus VP35 protein functions as a type I IFN antagonist.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Ebola virus VP40-induced particle formation and association with the lipid bilayer

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Ubiquitin and the control of protein fate in the secretory and endocytic pathways

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Epitopes involved in antibody-mediated protection from Ebola virus

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Infectivity-enhancing antibodies to Ebola virus glycoprotein

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Immunization for Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus

1 reference

https://api.crossref.org/works/10.1016/S0966-842X(01)02201-6

7 January 2021

10.1016/S0966-842X(01)02201-6

Identifiers

DOI

1 reference

30 July 2017

1 reference